Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Waldenström macroglobulinemia and relationship to immune deficiency.
Levy A, Guidez S, Debiais C, Princet I, Bouyer S, Dindinaud E, Delwail V, Systchenko T, Moya N, Gruchet C, Sabirou F, Bobin A, Gardeney H, Nsiala L, Cailly L, Olivier G, Motard C, Fleck E, Corby A, Roul C, Denis G, Dieval C, Leleu X, Tomowiak C. Levy A, et al. Among authors: systchenko t. Leuk Lymphoma. 2021 Nov;62(11):2665-2670. doi: 10.1080/10428194.2021.1907379. Epub 2021 Jun 4. Leuk Lymphoma. 2021. PMID: 34085595 Review.
Heavy + light chain analysis to assign myeloma response is analogous to the IMWG response criteria.
Fouquet G, Snell KI, Guidez S, Schraen S, Boyle E, Renaud L, Desmier D, Machet A, Moya N, Systchenko T, Gruchet C, Decaux O, Arnulf B, Fohrer C, Richez V, Kolb B, Macro M, Karlin L, Royer B, Pegourie B, Hebraud B, Caillot D, Perrot A, Moreau P, Facon T, Avet-Loiseau H, Dejoie T, Hulin C, Harding S, Leleu X. Fouquet G, et al. Among authors: systchenko t. Leuk Lymphoma. 2018 Mar;59(3):583-589. doi: 10.1080/10428194.2017.1339876. Epub 2017 Jul 12. Leuk Lymphoma. 2018. PMID: 28697637
Response to pneumococcal vaccination in multiple myeloma.
Renaud L, Schraen S, Fouquet G, Guidez S, Demarquette H, Nudel M, Cayssials E, Bories C, Herbaux C, Systchenko T, Faucompré JL, Machet A, Sabirou F, Levy A, Bobin A, Richez V, Moya N, Gruchet C, Desmier D, van de Wyngaert Z, Carpentier B, Manier S, Facon T, Harding S, Leleu X. Renaud L, et al. Among authors: systchenko t. Cancer Med. 2019 Jul;8(8):3822-3830. doi: 10.1002/cam4.2253. Epub 2019 May 30. Cancer Med. 2019. PMID: 31145552 Free PMC article.
Cost and efficacy of peripheral stem cell mobilization strategies in multiple myeloma.
Van de Wyngaert Z, Nerich V, Fouquet G, Chrétien ML, Caillot D, Azar N, Garderet L, Lenain P, Macro M, Bourhis JH, Belhocine R, Jaccard A, Karlin L, Bobin A, Moya N, Systchenko T, Gruchet C, Giraud C, Guidez S, Darras C, Princet I, Touzeau C, Moreau P, Hulin C, Deconinck E, Limat S, Leleu X; IFM (Intergroupe Français du Myélome – IFM 2014-05). Van de Wyngaert Z, et al. Among authors: systchenko t. Bone Marrow Transplant. 2020 Dec;55(12):2254-2260. doi: 10.1038/s41409-020-0940-3. Epub 2020 May 23. Bone Marrow Transplant. 2020. PMID: 32447348
Low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study.
Cayssials E, Torregrosa-Diaz J, Gallego-Hernanz P, Tartarin F, Systchenko T, Maillard N, Desmier D, Machet A, Fleck E, Corby A, Motard C, Denis G, Herbelin A, Gombert JM, Roy L, Ragot S, Leleu X, Guilhot F, Chomel JC. Cayssials E, et al. Among authors: systchenko t. Cancer. 2020 Aug 1;126(15):3438-3447. doi: 10.1002/cncr.32940. Epub 2020 May 27. Cancer. 2020. PMID: 32459375 Free article.
Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020.
Bobin A, Liuu E, Moya N, Gruchet C, Sabirou F, Lévy A, Gardeney H, Nsiala L, Cailly L, Guidez S, Tomowiak C, Systchenko T, Javaugue V, Durand G, Leleu X, Puyade M. Bobin A, et al. Among authors: systchenko t. Cancers (Basel). 2020 Oct 8;12(10):2885. doi: 10.3390/cancers12102885. Cancers (Basel). 2020. PMID: 33050025 Free PMC article. Review.
Hodgkin lymphoma and female fertility: a multicenter study in women treated with doxorubicin, bleomycin, vinblastine, and dacarbazine.
Machet A, Poudou C, Tomowiak C, Gastinne T, Gardembas M, Systchenko T, Moya N, Debiais C, Levy A, Gruchet C, Sabirou F, Noel S, Bouyer S, Leleu X, Delwail V, Guidez S. Machet A, et al. Among authors: systchenko t. Blood Adv. 2023 Aug 8;7(15):3978-3983. doi: 10.1182/bloodadvances.2021005557. Blood Adv. 2023. PMID: 36129842 Free PMC article.
11 results